Skip to Content
Merck

28-3500

Sodium nitroferricyanide(III) dihydrate

JIS special grade, ≥99.0%

Synonym(s):

Nitroprusside sodium, SNP, Sodium nitroprusside, Sodium pentacyanonitrosylferrate

Sign In to View Organizational & Contract Pricing.

Select a Size

About This Item

Linear Formula:
Na2[Fe(CN)5NO] · 2H2O
CAS Number:
13755-38-9
Molecular Weight:
297.95
UNSPSC Code:
12352300
PubChem Substance ID:
329753161
EC Number:
238-373-9
MDL number:
MFCD00149192
Assay:
≥99.0%
Grade:
JIS special grade
Form:
solid

Key Documents

View All Documentation
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

InChI key

OIRZWVYIQXBRFC-UHFFFAOYSA-N

InChI

1S/5CN.Fe.NO.2Na.2H2O/c5*1-2;;1-2;;;;/h;;;;;;;;;2*1H2/q;;;;;2*-1;2*+1;;

SMILES string

[Na+].[Na+].[H]O[H].[H]O[H].O=N[Fe--](C#N)(C#N)(C#N)(C#N)C#N

grade

JIS special grade

assay

≥99.0%

form

solid

reaction suitability

reagent type: catalyst
core: iron

availability

available only in Japan

Looking for similar products? Visit Product Comparison Guide

Related Categories

pictograms

Skull and crossbones
GHS06

signalword

Danger

hcodes

H301

Hazard Classifications

Acute Tox. 3 Oral

Storage Class

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Faceshields, Gloves, type P2 (EN 143) respirator cartridges

Regulatory Listings

Regulatory Listings are mainly provided for chemical products. Only limited information can be provided here for non-chemical products. No entry means none of the components are listed. It is the user’s obligation to ensure the safe and legal use of the product.

Substances Subject to be Indicated Names

ishl_indicated

Substances Subject to be Notified Names

ishl_notified

28-3500-2-25G-J: + 28-3500-5-500G-J:

jan

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
U6560
U5533
U2496
U4425
U0358

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Milos R Filipovic et al.
Journal of medicinal chemistry, 56(4), 1499-1508 (2013-02-20)
Hydrogen sulfide (H2S) has been increasingly recognized as an important signaling molecule that regulates both blood pressure and neuronal activity. Attention has been drawn to its interactions with another gasotransmitter, nitric oxide (NO). Here, we provide evidence that the physiological
Bas van den Bogaard et al.
American journal of hypertension, 26(4), 574-579 (2013-03-08)
Sodium nitroprusside (SNP) and labetalol are recommended for the immediate treatment of malignant hypertension. Both are intravenous agents but have different effects on systemic hemodynamics, and may have differential effects on pulse-wave reflection and pulse-pressure amplification, with consequences for peripheral
Galen W Heyne et al.
Investigative ophthalmology & visual science, 54(7), 5103-5110 (2013-06-27)
To determine the effect of the nitric oxide donor, sodium nitroprusside (SNP), and the nitric oxide synthase (NOS) inhibitor, L-nitro-arginine-methylester (L-NAME), on IOP, mean arterial pressure (MAP), pupil diameter (PD), refraction (Rfx), aqueous humor formation (AHF), and outflow facility (OF)
Song Guo et al.
Cephalalgia : an international journal of headache, 33(5), 301-307 (2013-02-14)
Sodium nitroprusside (SNP) is a powerful vasodilatory agent that, similarly to glyceryl trinitrate (GTN), releases nitric oxide (NO) but in contrast does not pass the blood-brain barrier. Nevertheless, it has already been used in animal models without any knowledge of
Christopher J Pelham et al.
American journal of physiology. Regulatory, integrative and comparative physiology, 304(9), R690-R701 (2013-03-01)
Agonists of the nuclear hormone receptor peroxisome proliferator-activated receptor γ (PPARγ) have potent insulin-sensitizing effects and inhibit atherosclerosis progression in patients with Type II diabetes. Conversely, missense mutations in the ligand-binding domain of PPARγ that render the transcription factor dominant
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service